Superworth

Biodesix shares outstanding BDSX

Diluted shares outstanding, averaged over each quarter, from 2019.

Latest quarter, to Jun 30, 2026
10.3M
On a year earlier
+40.4%
more shares

Biodesix had 10.3M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.

That is 40.4% more than a year earlier, so each share owns a little less of the company.

Shares outstanding over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearShares, fourth quarterChange
FY20258.1M+10%
FY20247.3M+59%
FY20234.6M+61%
FY20222.9M+112%
FY20211.4M+9960%
FY201913.4Kn/a

Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.

Quarter by quarter

QuarterEndedShares outstandingOn a year earlier
Q2 FY2610.3M+40%
Q1 FY269.7M+32%
Q4 FY258.1M+10%
Q3 FY257.5M+3%
Q2 FY257.3M+15%
Q1 FY257.3M+50%
Q4 FY247.3M+59%
Q3 FY247.3M+84%
Q2 FY246.4M+62%
Q1 FY244.9M+25%
Q4 FY234.6M+61%
Q3 FY234M+97%

What the shares outstanding tells you

Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.

A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.

More on Biodesix

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.